MeSH Browser

MeSH Heading: Benztropine
Tree Number(s): D02.145.074.722.270; D03.132.889.244; D03.605.084.500.722.270; D03.605.869.270
Unique ID: D001590
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D001590
Scope Note: A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.
Entry Term(s): Apo-Benztropine; Bensylate; Benzatropine; Benzatropine Mesylate; Benzatropine Methanesulfonate; Benzatropine Methanesulfonate, Hydrobromide; Benzatropine Methanesulfonate, Hydrobromide, (endo)-Isomer; Benzatropine Methanesulfonate, Hydrochloride, (endo)-Isomer; Benztropine Mesylate; Cogentin; Cogentinol; N-Methylbenztropine; PMS-Benztropine
Pharm Action: Antiparkinson Agents
Parasympatholytics
Muscarinic Antagonists
Dopamine Uptake Inhibitors
Related Numbers: 132-17-2; 25471-65-2; 6148-20-5; 80677-48-1; 86-13-5; WMJ8TL7510
CAS Type 1 Name: 8-Azabicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo-
Previous Indexing: Tropanes (1972-1990)
Public MeSH Note: 1991; see TROPANES 1972-1990; BENZATROPINE METHANESULFONATE was indexed under BENZOTROPINE 1977-2005
History Note: 1991(1972); use TROPANES 1972-1990
Date Established: 1991/01/01
Date of Entry: 1999/01/01
Revision Date: 2017/05/24

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Benztropine MeSH Descriptor Data 2024